{"id":"placebo-of-angongniuhuang-pill","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3770173","moleculeType":"Small molecule","molecularWeight":"440.32"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo for Angong Niuhuang pill (a traditional Chinese medicine formulation), this product is designed to serve as an inert control in a Phase 3 trial to assess the efficacy and safety of the active Angong Niuhuang pill. Placebos are used to establish whether observed clinical effects are due to the active drug or to non-specific factors such as patient expectation and natural disease progression.","oneSentence":"This is a placebo control arm in a clinical trial and contains no active pharmaceutical ingredient.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:27:59.305Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04475328","phase":"PHASE3","title":"Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2020-10-01","conditions":"Acute Ischemic Stroke","enrollment":120},{"nctId":"NCT03733002","phase":"PHASE3","title":"Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2018-12-01","conditions":"Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT00817609","phase":"PHASE2, PHASE3","title":"Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke","status":"UNKNOWN","sponsor":"Fudan University","startDate":"","conditions":"Stroke, Acute Ischemic Stroke","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo of Angong Niuhuang Wan"],"phase":"phase_3","status":"active","brandName":"Placebo of AngongNiuhuang pill","genericName":"Placebo of AngongNiuhuang pill","companyName":"Peking Union Medical College Hospital","companyId":"peking-union-medical-college-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}